Home / World News / Infectious disease specialists ask US govt to ensure remdesivir supply

Infectious disease specialists ask US govt to ensure remdesivir supply

Remdesivir is made by Gilead Sciences Inc, which has committed to supplying 500,000 treatment courses of the drug to HHS for distribution to US hospitals in July, August and September

Premium

The IDSA said remdesivir, available since May under an emergency use authorization from the Food and Drug Administration, has been a critical tool for reducing the strain on hospitals.

Deena Beasley | Reuters

2 min read Last Updated : Jul 18 2020 | 3:44 PM IST

U.S. infectious disease specialists this week asked the federal government to "use every authority it has" to ensure adequate supplies of the antiviral drug remdesivir as the number of people infected with the novel coronavirus continues to rise.

In a letter to Vice President Mike Pence and Secretary of Health and Human Services (HHS) Alex Azar, the Infectious Diseases Society of America (IDSA) expressed concern that developed countries are relying on a single manufacturer for the only antiviral so far shown to be effective against Covid-19, the disease caused by the coronavirus.

Remdesivir is made by Gilead Sciences Inc, which has committed

Topics : Coronavirus US government Coronavirus Vaccine

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in